{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T19:51:44Z","timestamp":1792353104122,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ajp.2023.103852","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T18:08:12Z","timestamp":1701281292000},"page":"103852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Immune-inflammatory markers of response to repetitive transcranial magnetic stimulation in depression: A scoping review"],"prefix":"10.1016","volume":"91","author":[{"given":"Ravi Philip","family":"Rajkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jad.2022.09.011","article-title":"Understanding treatment-resistant depression using \u201comics\u201d techniques: a systematic review","volume":"318","author":"Amasi-Hartoonian","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.ajp.2023.103852_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/npp.2012.237","article-title":"Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials","volume":"38","author":"Berlim","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/070674371105600104","article-title":"How does electroconvulsive therapy work? Theories on its mechanism","volume":"56","author":"Bolwig","year":"2011","journal-title":"Can. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2023.103852_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/acps.12730","article-title":"The acute-phase mediator serum amyloid A is associated with symptoms of depression and fatigue","volume":"135","author":"Bryleva","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"Aug","key":"10.1016\/j.ajp.2023.103852_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbi.2020.04.039","article-title":"Altered peripheral blood compounds in drug-na\u00efve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis","volume":"88","author":"Cakici","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"Mar","key":"10.1016\/j.ajp.2023.103852_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1017\/S0033291721000155","article-title":"Changes in peripheral blood compounds following psychopharmacological treatment in drug-na\u00efve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis","volume":"51","author":"Cakici","year":"2021","journal-title":"Psychol. Med."},{"issue":"Feb","key":"10.1016\/j.ajp.2023.103852_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ajp.2023.103852_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jad.2023.05.051","article-title":"Efficacy and safety of repetitive transcranial magnetic stimulation combined with antidepressants in children and adolescents with depression: a systematic review and meta-analysis","author":"Cao","year":"2023","journal-title":"J. Affect. Disord. (Sep 1)"},{"issue":"5","key":"10.1016\/j.ajp.2023.103852_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbi.2008.01.005","article-title":"The stressed prefrontal cortex. Left?","volume":"22","author":"Cerqueira","year":"2008","journal-title":"Right! Brain Behav. Immun."},{"issue":"Mar 1","key":"10.1016\/j.ajp.2023.103852_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2016.11.028","article-title":"Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: a systematic review and multiple-treatments meta-analysis","volume":"320","author":"Chen","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"Aug","key":"10.1016\/j.ajp.2023.103852_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbi.2020.06.024","article-title":"Antidepressant efficacy and immune effects of bilateral theta burst stimulation monotherapy in major depression: a randomized, double-blind, sham-controlled study","volume":"88","author":"Chou","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"13","key":"10.1016\/j.ajp.2023.103852_bib12","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1017\/S0033291722003567","article-title":"Reduced cerebral cortex thickness is related to overexpression of exosomal miR-146a-5p in medication-free patients with major depressive disorder","volume":"53","author":"Deng","year":"2023","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.ajp.2023.103852_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/YCT.0000000000000782","article-title":"The pattern of change in depressive symptoms and inflammatory markers after electroconvulsive therapy: a systematic review","volume":"37","author":"Desfosses","year":"2021","journal-title":"J. ECT"},{"issue":"Oct","key":"10.1016\/j.ajp.2023.103852_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","volume":"81","author":"Enache","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.ajp.2023.103852_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4306\/pi.2016.13.5.549","article-title":"Circulating plasma Micro RNAs in patients with major depressive disorder treated with antidepressants: a pilot study","volume":"13","author":"Enatescu","year":"2016","journal-title":"Psychiatry Invest."},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1205-6","article-title":"Serum amyloid A primes microglia for ATP-dependent interleukin-1\u03b2 release","volume":"15","author":"Facci","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/1673-5374.374140","article-title":"Contribution of glial cells to the neuroprotective effects triggered by repetitive transcranial magnetic stimulation: a systematic review","volume":"19","author":"Ferreira","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/YCT.0b013e31828b34d8","article-title":"Biological markers in non-invasive brain stimulation trials in major depressive disorder: a systematic review","volume":"30","author":"Fidalgo","year":"2014","journal-title":"J. ECT"},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.64719\/pb.4425","article-title":"Inflammatory biomarker and response to antidepressant in major depressive disorder: a systematic review and meta-analysis","volume":"52","author":"Gasparini","year":"2022","journal-title":"Psychopharmacol. Bull."},{"issue":"Mar","key":"10.1016\/j.ajp.2023.103852_bib20","article-title":"Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a meta-analysis","volume":"297","author":"Gay","year":"2021","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.ajp.2023.103852_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4088\/JCP.13r08815","article-title":"Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis","volume":"75","author":"Gaynes","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"Oct","key":"10.1016\/j.ajp.2023.103852_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.ajp.2023.103852_bib23","first-page":"97","article-title":"Transcranial magnetic stimulation: using a law of physics to treat psychopathology","volume":"24","author":"Hasey","year":"1999","journal-title":"J. Psychiatry Neurosci."},{"issue":"10","key":"10.1016\/j.ajp.2023.103852_bib24","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1017\/S0033291712000128","article-title":"Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis","volume":"42","author":"Hiles","year":"2012","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.ajp.2023.103852_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brs.2009.10.005","article-title":"Physiology of repetitive transcranial magnetic stimulation of the human brain","volume":"3","author":"Hoogendam","year":"2010","journal-title":"Brain Stimul."},{"issue":"Pt A","key":"10.1016\/j.ajp.2023.103852_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2016.09.003","article-title":"Overexpression of serum amyloid a 1 induces depressive-like behavior in mice","volume":"1654","author":"Jang","year":"2017","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.ajp.2023.103852_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biopsych.2006.09.033","article-title":"Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A","volume":"62","author":"Kling","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2023.103852_bib28","first-page":"4195","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis","volume":"55","author":"Kohler","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.ajp.2023.103852_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1159\/000350094","article-title":"Molecular mechanisms of depression: perspectives on new treatment strategies","volume":"31","author":"Lang","year":"2013","journal-title":"Cell Physiol. Biochem."},{"issue":"Jun 27","key":"10.1016\/j.ajp.2023.103852_bib30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00702-019-02037-5","article-title":"Treatment of patients with geriatric depression with repetitive transcranial magnetic stimulation","volume":"126","author":"Leblhuber","year":"2019","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.ajp.2023.103852_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.brs.2018.02.003","article-title":"A precision medicine approach to repetitive transcranial magnetic stimulation (rTMS)","volume":"11","author":"Leuchter","year":"2018","journal-title":"Brain Stimul."},{"issue":"4","key":"10.1016\/j.ajp.2023.103852_bib32","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1160\/TH15-08-0687","article-title":"Antithrombin: anti-inflammatory properties and clinical applications","volume":"115","author":"Levy","year":"2016","journal-title":"Thromb. Haemostat."},{"issue":"Aug 2","key":"10.1016\/j.ajp.2023.103852_bib33","article-title":"MicroRNA-146a-5p Mediates High Glucose-Induced Endothelial Inflammation via Targeting Interleukin-1 Receptor-Associated Kinase 1 Expression","volume":"8","author":"Lo","year":"2017","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.ajp.2023.103852_bib34","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1038\/s41380-020-00867-4","article-title":"The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression","volume":"26","author":"Mac Giollabhui","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"Nov","key":"10.1016\/j.ajp.2023.103852_bib35","article-title":"Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): a systematic review & meta-analysis","volume":"317","author":"Meshkat","year":"2022","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med. Res. Methodol."},{"issue":"Jun","key":"10.1016\/j.ajp.2023.103852_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.003","article-title":"IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms","volume":"146","author":"Ngwa","year":"2022","journal-title":"Mol. Immunol."},{"issue":"Oct","key":"10.1016\/j.ajp.2023.103852_bib38","article-title":"Cost-effectiveness analysis comparing repetitive transcranial magnetic stimulation therapy with antidepressant treatment in patients with treatment-resistant depression in Japan","volume":"330","author":"Noda","year":"2023","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.ajp.2023.103852_bib39","first-page":"22r03423","article-title":"Effectiveness of repetitive transcranial magnetic stimulation in depression, schizophrenia, and obsessive-compulsive disorder: an umbrella meta-analysis","volume":"25","author":"Patel","year":"2023","journal-title":"Prim. Care Companion CNS Disord."},{"issue":"Jul","key":"10.1016\/j.ajp.2023.103852_bib40","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.bbi.2020.02.016","article-title":"Endocrine and immune effects of non-convulsive neurostimulation in depression: a systematic review","volume":"87","author":"Perrin","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.ajp.2023.103852_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bpsc.2017.10.007","article-title":"Neuroimaging mechanisms of therapeutic transcranial magnetic stimulation for major depressive disorder","volume":"3","author":"Philip","year":"2018","journal-title":"Biol. Psychiatry Cogn. Neuroimag."},{"issue":"5","key":"10.1016\/j.ajp.2023.103852_bib42","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jnr.21206","article-title":"Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain","volume":"85","author":"Qin","year":"2007","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.ajp.2023.103852_bib43","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1471-4159.2009.06231.x","article-title":"Oxidized phosphatidylcholine formation and action in oligodendrocytes","volume":"110","author":"Qin","year":"2009","journal-title":"J. Neurochem."},{"issue":"Jan","key":"10.1016\/j.ajp.2023.103852_bib44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neubiorev.2021.12.008","article-title":"The neurobiology of treatment-resistant depression: a systematic review of neuroimaging studies","volume":"132","author":"Runia","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"Oct 28","key":"10.1016\/j.ajp.2023.103852_bib45","article-title":"Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder","volume":"12","author":"Song","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2023.103852_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1139\/cjpp-2018-0490","article-title":"Oxidized lipids: not just another brick in the wall","volume":"97","author":"Stamenkovic","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ajp.2023.103852_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246592","article-title":"Oxolipidomics profile in major depressive disorder: comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment","volume":"16","author":"Stirton","year":"2021","journal-title":"PLoS One"},{"issue":"Apr 8","key":"10.1016\/j.ajp.2023.103852_bib48","article-title":"Changes in interleukin-1 beta are significantly correlated with partial improvement of cognitive dysfunction in treatment-resistant depression: a pilot study","volume":"289","author":"Tateishi","year":"2020","journal-title":"Psychiatry Res"},{"issue":"Feb 24","key":"10.1016\/j.ajp.2023.103852_bib49","article-title":"Is the therapeutic mechanism of repetitive transcranial magnetic stimulation in cognitive dysfunctions of depression related to the neuroinflammatory processes in depression?","volume":"13","author":"Tateishi","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"Feb 27","key":"10.1016\/j.ajp.2023.103852_bib50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/npr2.12332","article-title":"Serum soluble triggering receptor expressed on myeloid cells-2 was not altered by rTMS in patients with treatment-resistant depression","volume":"43","author":"Tateishi","year":"2023","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"7","key":"10.1016\/j.ajp.2023.103852_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.ajp.2023.103852_bib52","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1111\/ejn.15232","article-title":"Brain stimulation effects on serum BDNF, VEGF, and TNF\u03b1 in treatment-resistant psychiatric disorders.","volume":"53","author":"Valiuliene","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"Aug 8","key":"10.1016\/j.ajp.2023.103852_bib53","article-title":"Anti-neuroinflammatory microRNA-146a-5p as a potential biomarker for neuronavigation-guided rTMS therapy success in medication resistant depression disorder","volume":"166","author":"Valiuliene","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.PSY.0000039753.23250.20","article-title":"Association of negative life event stress with coagulation activity in elderly Alzheimer caregivers","volume":"65","author":"von Kanel","year":"2003","journal-title":"Psychosom. Med."},{"issue":"3","key":"10.1016\/j.ajp.2023.103852_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.psychres.2004.02.003","article-title":"Effects of depressive symptoms and anxiety on hemostatic responses to acute mental stress and recovery in the elderly","volume":"126","author":"von Kanel","year":"2004","journal-title":"Psychiatry Res"},{"issue":"Jun 2","key":"10.1016\/j.ajp.2023.103852_bib56","article-title":"Inflammatory cytokines changed in patients with depression before and after repetitive transcranial magnetic stimulation treatment","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-018-0583-x","article-title":"Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS)","volume":"18","author":"Wirsching","year":"2018","journal-title":"BMC Med. Res. Methodol."},{"issue":"Sep 14","key":"10.1016\/j.ajp.2023.103852_bib58","article-title":"Combined repetitive transcranial magnetic stimulation and medication treatment for depression is associated with serum amyloid A level: evidence from naturalistic clinical practice","volume":"16","author":"Xu","year":"2022","journal-title":"Front. Neurosci."},{"issue":"25","key":"10.1016\/j.ajp.2023.103852_bib59","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1523\/JNEUROSCI.2312-22.2023","article-title":"Elevated galectin-3 is associated with aging, multiple sclerosis, and oxidized phosphatidylcholine-induced neurodegeneration","volume":"43","author":"Xue","year":"2023","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1189\/jlb.3VMA1215-579RR","article-title":"Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages","volume":"101","author":"Yeon","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"Nov 5","key":"10.1016\/j.ajp.2023.103852_bib61","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00702-022-02553-x","article-title":"A kynurenine pathway enzyme aminocarboxymuconate\u2011semialdehyde decarboxylase may be involved in treatment\u2011resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study","volume":"129","author":"Yilmaz","year":"2022","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brs.2017.10.013","article-title":"Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review","volume":"11","author":"Yrondi","year":"2018","journal-title":"Brain Stimul."},{"issue":"1","key":"10.1016\/j.ajp.2023.103852_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2005.12.029","article-title":"Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients","volume":"91","author":"Zanardini","year":"2006","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.ajp.2023.103852_bib64","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1177\/0300060518817417","article-title":"Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1\u03b2 and tumor necrosis factor-\u03b1 in elderly patients with refractory depression","volume":"47","author":"Zhao","year":"2019","journal-title":"J. Int. Med. Res."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201823004094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201823004094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:49:45Z","timestamp":1761756585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201823004094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":64,"alternative-id":["S1876201823004094"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2023.103852","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-inflammatory markers of response to repetitive transcranial magnetic stimulation in depression: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2023.103852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103852"}}